Jianmei Fan

USPTO Granted Patents = 16 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 9.4

ph-index = 5

Forward Citations = 55(Granted Patents)

Location History:

Hamden, CT (US) (2006 - 2011)
Cambridge, MA (US) (2013 - 2016)
Newton, MA (US) (2008 - 2018)

Company Filing History:

Bayer Pharmaceuticals Corporation

Years Active: 2006-2018

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE46942 - 4-piperidinyl compounds for use as tankyrase inhibitors (2018-07-09),

2. 9227982 - 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors (2016-01-05),

3. 9181266 - 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors (2015-11-10),

4. 9163003 - 4-piperidinyl compounds for use as tankyrase inhibitors (2015-10-20),

5. 8349883 - Hydroxamate-based inhibitors of deacetylases B (2013-01-08),

6. 8338595 - Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis (2012-12-25),

7. 8076488 - Bicyclic urea derivatives useful in the treatment of cancer and other disorders (2011-12-13),

8. 7943652 - Hydroxamate-based inhibitors of deacetylases B (2011-05-17),

9. 7803956 - Benzofuran derivatives useful for treating hyper-proliferative disorders (2010-09-28),

10. 7659412 - Benzofuran derivatives useful for treating hyper-proliferative disorders (2010-02-09),

11. 7585888 - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders (2009-09-08),

12. 7563791 - Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis (2009-07-21),

13. 7557129 - Cyanopyridine derivatives useful in the treatment of cancer and other disorders (2009-07-07),

14. 7420066 - Benzofuran derivatives useful for treating hyper-proliferative disorders (2008-09-02),

15. 7351735 - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders (2008-04-01),

Title: **Innovative Contributions of Inventor Jianmei Fan**

Introduction:

Jianmei Fan, based in Newton, MA, is a distinguished inventor with an impressive portfolio of 16 patents. Her innovative work primarily focuses on developing pharmaceutical compounds for critical medical applications, particularly in the field of cancer treatment.

Latest Patents:

Among her latest patents are two notable inventions:

1. **4-piperidinyl compounds for use as tankyrase inhibitors**: This invention provides compounds of formula (I), where R, R', and n are defined within the patent. The compounds are designed for pharmaceutical compositions aimed at inhibiting tankyrase, which plays a significant role in Wnt signaling and is associated with cancer and related disorders.

2. **4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrimidinyl compounds for use as tankyrase inhibitors**: Similarly, this invention outlines compounds of formula (I), with R and R' defined. It also focuses on pharmaceutical compositions that utilize these compounds to inhibit tankyrase and target Wnt signaling disorders, including various forms of cancer.

Career Highlights:

Jianmei Fan has had a commendable career in the pharmaceutical industry, having worked with esteemed companies like Novartis AG and Bayer Pharmaceuticals Corporation. Her contributions in these roles have significantly impacted drug discovery, particularly regarding treatments for oncological applications.

Collaborations:

Throughout her career, Jianmei has collaborated with distinguished professionals in her field, including Barton W. Phillips and Jacques P. Dumas. These partnerships have fostered an environment of innovation and advancement within her research endeavors.

Conclusion:

Jianmei Fan's dedication to innovation in the pharmaceutical sector has led to significant advancements in the treatment of cancer and related disorders. With her 16 patents, she continues to contribute meaningfully to science and medicine, showcasing the importance of inventors in developing solutions that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.